NCT05094804 2023-11-02A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer AgentsOncoResponse, Inc.Phase 1/2 Unknown172 enrolled
NCT05548179 2023-03-06Exploring Clinical Trial Experiences of People With LeiomyosarcomaPower Life Sciences Inc.Unknown500 enrolled